W2O Group's president and author of Storytizing, Bob Pearson spoke at the US Chamber of Commerce's #healthforward event. He shared key insights on innovations in healthcare.
Innovations in Healthcare - US Chamber of Commerce Maya Ollie
W2O Group's president and author of Storytizing, Bob Pearson spoke at the US Chamber of Commerce's #healthforward event. He shared key insights on innovations in healthcare.
Presentation from a talk I gave at the Nottingham AI meetup. In this talk I explored some of the practical applications of medical AI, the research surrounding this exciting field and the potential for AI to be utilised as a support tool in healthcare and medicine. The talk will take high level view of the technology and it's application as apposed to a low level technical analysis, making it accessible to everyone.
Swiss Re - Center for Global Dialogue Report: Healthcare revolution: Big dat...Thomas Dijohn
dacadoo is proud to be referenced by Swiss Re - Center of Global Dialogue in report 'Healthcare revolution: Big data and smart analytics'.
dacadoo is referenced in the section "Sensor innovations driving the digital health revolution"
For the 5th year, we culminated the best of the DayOne Healthcare Innovation initiative: hot topics, open debates, smart insights, bright ideas, high energy personalities and tangible expertise. This will include the Open Innovation Session that brings together the Health Hack and is a springboard for the Accelerator. The panel sessions included: The patient centric approach + four bright ideas; How to make it happen; + The healthcare innovation journey.
This year’s conference joined forces with BioData Congress 2020 in a virtual format. Thank you to the partners Arcondis and Innosuisse, as well as all the mentors, coaches and behind the scenes work to pull this all together in a great event wtih over 800 participants.
Innovations in Healthcare - US Chamber of Commerce Maya Ollie
W2O Group's president and author of Storytizing, Bob Pearson spoke at the US Chamber of Commerce's #healthforward event. He shared key insights on innovations in healthcare.
Presentation from a talk I gave at the Nottingham AI meetup. In this talk I explored some of the practical applications of medical AI, the research surrounding this exciting field and the potential for AI to be utilised as a support tool in healthcare and medicine. The talk will take high level view of the technology and it's application as apposed to a low level technical analysis, making it accessible to everyone.
Swiss Re - Center for Global Dialogue Report: Healthcare revolution: Big dat...Thomas Dijohn
dacadoo is proud to be referenced by Swiss Re - Center of Global Dialogue in report 'Healthcare revolution: Big data and smart analytics'.
dacadoo is referenced in the section "Sensor innovations driving the digital health revolution"
For the 5th year, we culminated the best of the DayOne Healthcare Innovation initiative: hot topics, open debates, smart insights, bright ideas, high energy personalities and tangible expertise. This will include the Open Innovation Session that brings together the Health Hack and is a springboard for the Accelerator. The panel sessions included: The patient centric approach + four bright ideas; How to make it happen; + The healthcare innovation journey.
This year’s conference joined forces with BioData Congress 2020 in a virtual format. Thank you to the partners Arcondis and Innosuisse, as well as all the mentors, coaches and behind the scenes work to pull this all together in a great event wtih over 800 participants.
June 2016 - Philadelphia SEO Grail PresentationJeff Louella
I've always been tired of SEO Presentations that don't give you solutions. "Do Great Things" is not actionable. While I don't give away the house in this presentation slide deck, I do give away some tools I built to be a more efficient technical SEO.
20150717_情報漏洩, マイナンバー, ビッグデータ/IoTセキュリティ対応を見据えた これからのセキュリティ対策のポイント by 笹原英司Insight Technology, Inc.
本セッションでは、情報漏洩、マイナンバー、ビッグデータ/IoTセキュリティといった、日本国内の企業が直面する課題と対策のポイントについて解説します。また、セキュリティ対策の最新トレンドについては、米国の事例をあげながら、セキュリティ対策を実行に移す上で重要な役割を担う、Chief Data Officer(チーフデータオフィサー)についてや、アプリケーションレイヤーからインフラレイヤーや移行しつつある米国の最新セキュリティ対策事情についても紹介します。
The healthcare industry is undergoing change at unprecedented speed and magnitude, yet continues to be fraught with cost inefficiencies and disappointing clinical outcomes. In this slides you will explore an outline of the current healthcare revolution, and how innovative technology strategies, models and tools are helping improve efficiency, effectiveness, and patient experiences.
The 3 Key Barriers Keeping Companies from Deploying Data Products Dataiku
Getting from raw data to deploying data-driven solutions requires technology, data, and people. All of which exist. So why aren’t we seeing more truly data-driven companies: what's missing and why? During Strata Hadoop World Singapore 2015, Pauline Brown, Director of Marketing at Dataiku, explains how lack of collaboration is what is keeping companies from building and deploying data products effectively. Learn more about Dataiku and Data Science Studio: www.dataiku.com
The Pharma 2020 series
The Pharmaceutical industry's long successful strategy of placing big bets on a few molecules, promoting them heavily and turning them into blockbusters worked well for many years, but its R&D productivity has now plummeted and the environment’s changing. PwC believes that seven major trends are reshaping the marketplace:
Source of info:
http://www.pwc.com/gx/en/pharma-life-sciences/pharma2020/index.jhtml#
Cemal H. Guvercin MedicReS 5th World Congress MedicReS
Ethical Issues in Artifical Intelligence Applied to Medicine Presentation to MedicReS 5th World Congress on October 19,25,2015 in New York by Cemal H. Guvercin, MD, PhD
Promise and peril: How artificial intelligence is transforming health careΔρ. Γιώργος K. Κασάπης
AI has enormous potential to improve the quality of health care, enable early diagnosis of diseases, and reduce costs. But if implemented incautiously, AI can exacerbate health disparities, endanger patient privacy, and perpetuate bias. STAT, with support from the Commonwealth Fund, explored these possibilities and pitfalls during the past year and a half, illuminating best practices while identifying concerns and regulatory gaps. This report includes many of the articles we published and summarizes our findings, as well as recommendations we heard from caregivers, health care executives, academic experts, patient advocates, and others.
Kim Solez tech&future of medicine for med students fall 2017Kim Solez ,
Kim Solez technology&future of medicine for med students fall 2017 Oct. 6, 2017 at the University of Alberta in Edmonton, Alberta, Canada. Copyright (c) 2017, JustMachines Inc.
June 2016 - Philadelphia SEO Grail PresentationJeff Louella
I've always been tired of SEO Presentations that don't give you solutions. "Do Great Things" is not actionable. While I don't give away the house in this presentation slide deck, I do give away some tools I built to be a more efficient technical SEO.
20150717_情報漏洩, マイナンバー, ビッグデータ/IoTセキュリティ対応を見据えた これからのセキュリティ対策のポイント by 笹原英司Insight Technology, Inc.
本セッションでは、情報漏洩、マイナンバー、ビッグデータ/IoTセキュリティといった、日本国内の企業が直面する課題と対策のポイントについて解説します。また、セキュリティ対策の最新トレンドについては、米国の事例をあげながら、セキュリティ対策を実行に移す上で重要な役割を担う、Chief Data Officer(チーフデータオフィサー)についてや、アプリケーションレイヤーからインフラレイヤーや移行しつつある米国の最新セキュリティ対策事情についても紹介します。
The healthcare industry is undergoing change at unprecedented speed and magnitude, yet continues to be fraught with cost inefficiencies and disappointing clinical outcomes. In this slides you will explore an outline of the current healthcare revolution, and how innovative technology strategies, models and tools are helping improve efficiency, effectiveness, and patient experiences.
The 3 Key Barriers Keeping Companies from Deploying Data Products Dataiku
Getting from raw data to deploying data-driven solutions requires technology, data, and people. All of which exist. So why aren’t we seeing more truly data-driven companies: what's missing and why? During Strata Hadoop World Singapore 2015, Pauline Brown, Director of Marketing at Dataiku, explains how lack of collaboration is what is keeping companies from building and deploying data products effectively. Learn more about Dataiku and Data Science Studio: www.dataiku.com
The Pharma 2020 series
The Pharmaceutical industry's long successful strategy of placing big bets on a few molecules, promoting them heavily and turning them into blockbusters worked well for many years, but its R&D productivity has now plummeted and the environment’s changing. PwC believes that seven major trends are reshaping the marketplace:
Source of info:
http://www.pwc.com/gx/en/pharma-life-sciences/pharma2020/index.jhtml#
Cemal H. Guvercin MedicReS 5th World Congress MedicReS
Ethical Issues in Artifical Intelligence Applied to Medicine Presentation to MedicReS 5th World Congress on October 19,25,2015 in New York by Cemal H. Guvercin, MD, PhD
Promise and peril: How artificial intelligence is transforming health careΔρ. Γιώργος K. Κασάπης
AI has enormous potential to improve the quality of health care, enable early diagnosis of diseases, and reduce costs. But if implemented incautiously, AI can exacerbate health disparities, endanger patient privacy, and perpetuate bias. STAT, with support from the Commonwealth Fund, explored these possibilities and pitfalls during the past year and a half, illuminating best practices while identifying concerns and regulatory gaps. This report includes many of the articles we published and summarizes our findings, as well as recommendations we heard from caregivers, health care executives, academic experts, patient advocates, and others.
Kim Solez tech&future of medicine for med students fall 2017Kim Solez ,
Kim Solez technology&future of medicine for med students fall 2017 Oct. 6, 2017 at the University of Alberta in Edmonton, Alberta, Canada. Copyright (c) 2017, JustMachines Inc.
PLEASE POST EACH DISCUSSION SEPARATELYEach healthcare organisamirapdcosden
PLEASE POST EACH DISCUSSION SEPARATELY
Each healthcare organization has its own internal policies related to how data is managed. There are also
federal guidelines and regulations
regarding the use of patient data. The data harvested by healthcare organizations is no longer uniquely derived from HIT systems.
Wearable technologies
have emerged in the market. Mega companies like Apple and Samsung, have also teamed up with some telehealth platforms to connect doctors, institutions, and insurance companies.
Evaluate the impact of data derived from wearable technology on healthcare technology.
Include the following aspects in the discussion:
Select
Apple's Health Kit
or another consumer platform of your choice.
Discuss how the consumer wearable market is changing the healthcare delivery process.
Summarize why cybersecurity continues to be a major obstacle to consumer wearable adoption specifically in the H.I.T. space.
Discuss your personal perspective on how the lack of ethnic diversity in data collection impacts the future of healthcare research.
REPLY TO 2 OF MY CLASSMATES DISCUSSION TO THE ABOVE QUESTIONS AND EXPLAIN WHY YOU AGREE. MINIMUM OF 150 WORDS EACH
CLASSMATE POST 1
The Apple Health Kit and the many other wearable device technology is creating data in a bountiful way. What the Health Kit does is collect the relevant data and process it specifically for the person wearing the device. The device monitors things such as blood pressure, heart rate, calories burned in a day etc. and that data can be directly sent to your doctor as well. The wearable market is impacting healthcare in that it is making it more accessible, and your data is becoming more personable. If something is on you every day it will learn your habits, your sleep patterns, your calories burned each day and be able to tell you where improvements could be made and commend a healthy change. According to the International Journal of Recent Research Aspects the number of connected medical devices is expected to increase from 10 billion to 50 billion over the next decade (Chawala, 2020). With an increased number of connected devices, it also increases the likelihood of someone accessing private information that is not a health care team member. Cyber security is becoming as important as homeland security as most attackers can do the same damage anonymously and behind a computer screen. The problem with wearable devices is that they are connected mainly via Bluetooth which is a public network were others could see the device connected. Secondly, the data that is being sent or monitored could be interfered while in transmission or an apple watch or device could be stolen that has all the owner’s information freely on it. Despite the tracking and privacy networks they have installed, it is easily overcome or stolen off a wrist.
The ethical concerns in the lack of diversity in data entry is inter ...
AI – Opportunities and Challenges in Transforming the Biopharma Value ChainEY
These slides were presented by Pamela Spence, EY Global Life Sciences Industry Leader, at the annual BIO International Convention on 20 June 2017. Pamela led a panel discussion on Artificial Intelligence (AI) and the opportunities and challenges it presents in transforming the biopharma value chain. The panelists included Dr. Attul Butte, Director of the Institute for Computational Health Science at the University of California – San Francisco, Iya Khalil, Chief Commercial Officer and Co-founder of GNS Healthcare, Nathan Price, Associate Director of the Institute for Systems Biology and co-founder of Arivale, and Jackie Hunter, CEO of Benevolent AI
In medical technologies, the potential of mRNA is thought to extend beyond the realm of vaccinations. Since mRNA can code for almost any protein, the same basic technique could theoretically pave the way for the creation of an enormous number of therapeutic interventions, each of which would work in much the same way as medicine.
Kim Solez tech&future of medicine for med students fall 2016 1Kim Solez ,
Dr. Kim Solez presents "Technology and the Future of Medicine for Medical Students" on Friday October 21st, 2016 at the University of Alberta in Edmonton, Alberta, Canada.
Australia-India: Combining Technology and Entrepreneurship to InnovateKiran Shaw
This is the full text of the speech given by Dr. Kiran Mazumdar Shaw at the Australian National University, as part of the K.R. Narayanan Oration series on the 2nd of March, 2015. She spoke about building India-Australia high-tech business cooperation through start-ups.The K R Narayanan Oration Series at the Australia South Asia Research Centre in The Australian National University has been devoted to in-depth examination of this important issue by leading experts.
Similar to Innovations in Healthcare - US Chamber of Commerce (20)
Common Sense for the C-Suite: Relevance is the New ReputationW2O Group
In today’s social/digital reality, Relevance has become the new reputation. This means that an organization must connect consistently and authentically on multiple levels with its key audiences — in areas that are both meaningful to the business- its core purpose and strategic direction - as well as areas that are meaningful to its audiences. What makes this different is the speed at which relevance forms and dissipates and the agility necessary to harness it for sustained growth and success.
In an age where information is ubiquitous and people move from one subject to another in a blink of eye, if your brand, product, service or company isn’t on their radar you don’t exist.
It’s all about connection.
In this issue of Common Sense for the C-Suite, we explore how organizations can drive growth and remain relevant in a crowded, distracted landscape.
Understanding Physician/ Patient Conversations OnlineW2O Group
MDigitalLife's Managing Director & Founder, Greg Matthews led a webinar discussing the evolution of online interactions between patients and Healthcare Providers (HCPs) and what healthcare companies need to know to stay ahead of the curve.
Online Conversations: From Understanding to Action and SuccessW2O Group
Article by Dana M Lewis illustrating the MDigitalLife Integrated Healthcare Approach developed exclusively for clients of the W2O Group. Article originally appeared in Healthcare Strategy Alert! Issue 1 2016, published by the Forum for Healthcare Strategists.
Network scoring for 2015 healthcare conferencesW2O Group
Using the proprietary MDigitalLife Online Network Scoring Algorithm, we compared 8 different healthcare conferences from the past year. The presentation debuted during the JP Morgan Healthcare Conference in January of 2016. A full writeup of the results and methodology can be found here (Scoring online networks – and why ASH and ASCO are better | http://bit.ly/1n3zRk4)
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Innovations in Healthcare - US Chamber of Commerce
1. Innovations in Healthcare
Key Drivers of Change
October 18, 2016
US Chamber of Commerce
Washington, DC
1 Contents are proprietary and confidential.
2. Three Major Drivers of Innovation
SCIENCEBIG DATA AI, MACHINE LEARNING &
NEURAL NETWORKS
2 Contents are proprietary and confidential.
The Information Genome
Everything we do, inside
or out, can be monitored
Our bodies and all we do
are the next frontier for
search
Patterns = Products Personalization becomes
mainstream
Our intellectual capital is
magnified when we
enable software to learn
on its own
Pattern-based learning
will lead to more
personalized solutions
The combination of
science and technology
opens up new thinking for
treatment, services and
solutions
3. And often require previously unrelated areas to merge
Innovation eras take time to develop
3
The Web
First plan for WWW in 1989
The genome meets its match
with AI
Precision of knowledge powers
rare disease innovation
Health data attracts
technology entrepreneurs
Time
Artificial Intelligence
1952-56 timeframe
Human Genome Project
Launched 1990
Completed 2003
4. A look at how our future is forming……
4 Contents are proprietary and confidential.
5. What if we combine high volume semiconductor
and pharmaceutical technology?
5 Contents are proprietary and confidential.
6. An ingestible sensor the size of a grain of sand, a
patch, an app and a provider portal are combined
We can track patients thousands of miles away,
see if they took the medicine, what their
pharmacokinetics are and where it was made
This is Proteus Digital Health
6 Contents are proprietary and confidential.
7. What if we could figure out how to edit disease?
7 Contents are proprietary and confidential.
8. The CRISPR–Cas9 system
Treat and edit disease
Target and study particular DNA sequences
Send proteins to precise DNA targets to turn genes
on or off
Bayer & CRISPR Therapeutics form JV
8 Contents are proprietary and confidential.
9. What new medical disciplines will form as a
result of technology and healthcare
converging?
9 Contents are proprietary and confidential.
10. Bioelectronics medicine
A new discipline combining molecular medicine, neurophysiology, biomedical
engineering, deciphering and manipulating the electrical signal produced by the
nervous system to communicate information
Neural bypass technology allowed a paralyzed person, for the first time, to regain
movement through the use of a brain implant. Therapies can be developed that
work by recording, stimulating, and blocking neural signaling
Chad Bouton and The Feinstein Institute for Medical Research
10 Contents are proprietary and confidential.
11. What is the promise of virtual reality in health?
11 Contents are proprietary and confidential.
12. Train physicians anywhere in the world
Distract burn victims via VR and decrease their
pain
Help veterans learn to deal with PTSD
It is a matter of our applied imagination
12 Contents are proprietary and confidential.
13. What if we can unlock the power of our immune
system to fight disease and replace more toxic
therapies?
13 Contents are proprietary and confidential.
14. The power of Immunotherapy
Anti PD-1 immunotherapy blocks the pathway so
our immune system can do its job
14 Contents are proprietary and confidential.
15. How can technology and machines improve
what humans do?
15 Contents are proprietary and confidential.
17. What new minds are tackling health issues?
17 Contents are proprietary and confidential.
18. Jeff Huber (Google) joins newly formed Grail, a
joint venture of Illumina, Jeff Bezos, Bill Gates
& Google Ventures
Goal: develop a proactive cancer-detecting blood
test to identify the tiny bits of cancer DNA that
are hanging out in our blood but are currently
undetectable.
18 Contents are proprietary and confidential.
19. What if all or most of our health data could be
integrated?
19 Contents are proprietary and confidential.
20. The equivalent of our data immune system
Will we unlock its power?
20 Contents are proprietary and confidential.
21. Personalization is being redefined
Your body is an untapped data source
Data, AI and robotics are drivers of innovation
Any disease or disorder is fair game today
21 Contents are proprietary and confidential.
22. The United States of America has an
unprecedented opportunity to drive a new era of
innovation
Technology and Healthcare partnerships will
lead to exponential advance for the next few
decades
22 Contents are proprietary and confidential.
23. Innovation will accelerate at a greater pace
in the years ahead
23 Contents are proprietary and confidential.
25. Political and business interests must align
around improving the health of all people
25 Contents are proprietary and confidential.
26. Our role in supporting innovators
Will we create an environment that can accelerate innovation, transform health outcomes and drive our
economy?
Clarity of Rules
How we regulate
Ambiguity stifles
investment
Clarity of Payment
Return on investment
If payment is unclear,
entrepreneurs find other
things to innovate
Ability to Learn
Together
The Role of FDA
FDA and innovators should
commit to learn together,
stay on top of what’s next
and evolve thinking at the
same pace
Ability to Evolve
Together
New regulations
If we evolve together, we
save years, even decades
of misaligned regulatory
standards and innovative
advances
27. Everyone is counting on us to succeed!
The journey continues….
27 Contents are proprietary and confidential.